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Abstract Escherichia coli has been widely used for the
production of recombinant proteins. To improve protein
production yields inE. coli, directed engineering approaches
have been commonly used. However, there are only few
reported examples of the isolation of E. coli protein pro-
duction strains using evolutionary approaches. Here, we first
give an introduction to bacterial evolution and mutagenesis
to set the stage for discussing how so far selection- and
screening-based approaches have been used to isolate E. coli
protein production strains. Finally, we discuss how evolu-
tionary approachesmay be used in the future to isolateE. coli
strains with improved protein production characteristics.
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Introduction
By the end of the nineteenth century, the German micro-
biologist Theodor Escherich discovered a fast-growing
bacterium that was called Escherichia coli after its
discoverer. E. coli has become one of the most important
model organisms in biology and the main workhorse in
biotechnology. As a model organism, E. coli has been
widely used to study evolution, and in biotechnology, it has
been routinely used for the production of recombinant
proteins [1]. However, recombinant protein production
yields and the quality of the produced material are often
not satisfactory. To create E. coli strains with improved
protein production characteristics, directed engineering
approaches, like deleting genes encoding proteases and co-
expressing genes encoding molecular chaperones, have
been commonly used [2]. However, thus far, there have
been only few reported examples of the isolation of E. coli
protein production strains using evolutionary, i.e., screen-
ing- and selection-based approaches. Aim of this review is
to discuss the in-our-opinion most relevant examples. To
set the stage for this, we first give an overview of some in-
our-opinion critical basics of bacterial evolution and
mutagenesis. Based on our own experience, such an
overview is very useful if one is interested in evolving
E. coli strains for protein production, but does not have a
background in bacterial genetics. However, those who are
familiar with bacterial evolution and mutagenesis may skip
the overview and immediately go to the section ‘E. coli as a
platform for the production of recombinant proteins’.
Evolution of bacteria
Evolution is defined as the change in heritable traits of
biological populations over successive generations and is a
continuously ongoing process. At the basis of evolution are
mutations, which are heritable changes in the DNA
sequence that can be faithfully replicated. Thus, only a
permanent change constitutes a mutation.
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How do changes in heritable traits in bacteria occur? For a
long time, it was not clear if bacteria somehow adapt to an
environment by a process of directed change or if constantly
spontaneous mutations occur that subsequently can be
selected for. In 1943, Salvador Luria and Max Delbru¨ck
tested these two hypotheses, the random-mutagenesis
hypothesis and the directed change hypothesis, in a landmark
study [3] (Fig. 1). Luria and Delbru¨ck used E. coli and the
bacteriophage T1, which kills E. coli, as selective agent.
However, mutations in the genes encoding the cell-envelope
proteins TonA (a.k.a. FhuA) and TonB can make E. coli
resistant against this bacteriophage [4]. In their study, Luria
and Delbru¨ck used (i) a single culture for spreading aliquots
ofE. coli cells on plates containing bacteriophageT1, and (ii)
multiple independent cultures for spreading aliquots of
E. coli cells on plates containing bacteriophage T1. Only
bacteria resistant to bacteriophage T1 would survive and
form colonies on the bacteriophage T1 containing plates,
allowing estimating the number of bacteriophage T1 resis-
tant bacteria in the aforementioned cultures. Using the single
culture, the number of bacteriophage T1 resistant mutants in
each aliquot was almost the same, whereas the number of
resistant mutants in aliquots of the multiple independent
cultures varied a lot. These results were in line with the
random-mutagenesis hypothesis; i.e., mutations occur
before selection rather than being induced by the selecting
agent. In 1952, Esther and Joshua Lederberg showed that
pre-existing mutations in bacteria that had never been
exposed to an antibiotic could render them antibiotic-resis-
tant [5], thus providing even more compelling evidence in
support of the random-mutagenesis hypothesis.
DNA integrity and mutagenesis
Being able to maintain the integrity of its DNA during
replication and upon damage is key to E. coli survival.
DNA replication is driven by DNA polymerases (P), and
mistakes made by the DNAPs can introduce mutations.
Also damage to DNA, i.e., a lesion, which can constitute a
chemical alteration of a base, sugar or phosphate, can lead
to mutations. In the following sections, we will give a
succinct introduction to the different types of mutations
and the major players involved in maintaining DNA
integrity in E. coli, i.e., its DNAPs and DNA-repair sys-
tems. Finally, we will introduce the main global regulatory
networks and some other important factors that can affect
DNA integrity and mutagenesis in E. coli.
Fig. 1 The Luria and Delbru¨ck experiment. In 1943, Luria and
Delbru¨ck devised an experiment to address if mutations occur prior to
selection or in response to it (‘mutation’ versus ‘acquired hereditary
immunity’) [3]. Several aliquots from single E. coli cultures and from
multiple, independent E. coli cultures were spread on plates
containing bacteriophage T1 (‘virus a’). On these plates, only
bacteria resistant (immune) to bacteriophage T1 survive and form
colonies. This allowed estimating the number of bacteriophage T1
resistant bacteria in the cultures. In aliquots from the same culture,
variation observed in the number of bacteriophage T1 resistant
mutants was minor and could be attributed to experimental error. In
contrast, the number of resistant mutants in aliquots of the multiple
independent cultures varied greatly. Luria and Delbru¨ck concluded
that, in this setup, ‘resistance to virus is due to a heritable change of
the bacterial cell which occurs independently of the action of the
virus’ (cit. [3])
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Types of mutations
Mutations can, in theory, occur anywhere in the genome,
and based on their effect on the fitness of the bacterium,
they can either be neutral, deleterious or beneficial. It has
been estimated that the majority of mutations (50–70 %)
has no effect on fitness, 30–50 % are likely to be detri-
mental or lead to a complete loss of viability, and only very
few mutations are expected to be beneficial (0.01–1 %) [6].
It should be kept in mind that a mutation that is beneficial
under certain circumstances may be neutral or even have
deleterious effects if conditions change.
At the sequence level, mutations are commonly grouped
according to the nature of the change relative to the ancestral
sequence into base substitutions, insertions, deletions,
inversions and translocations [4] (Fig. 2a–c). In a base sub-
stitution, one nucleobase is exchanged for another. If a
purine (adenine or guanine) is exchanged for the other purine
or a pyrimidine (cytosine or thymine) is replaced by the other
pyrimidine, the resulting change is called a base transition. In
a transversion, the purines are changed into pyrimidines and
the other way around. Base pair changes can occur as a result
of internal factors like mis-pairing during replication,
spontaneous deamination, or oxidation of bases by reactive
oxygen species. External factors like irradiation or added
chemicals can also induce base pair changes.
Deletions and insertions are often referred to as indels.
In small indels, a single or several base pairs are removed
or added to the DNA. Head-to-tail oriented repeats of the
same base-pair units, so-called short tandem DNA repeats
(STRs), are considered hotspots for the occurrence of small
indels due to strand slipping and misalignment during DNA
replication, or recombination events [7–9]. Hotspots are
regions in the genome that are more likely to acquire
mutations than others [10]. Larger deletions and insertions,
as well as sizeable inversions that can affect entire genomic
regions are primarily thought to be caused by recombina-
tion events between homologous regions, like rRNA genes,
prophages, and transposable elements (i.e., transposons and
IS-elements), that are present at several sites in the genome
(e.g., [11–15]). However, as for STRs, even distant
sequence repeats that are only a few nucleotides in length
may lead to smaller and larger alterations (e.g., [8, 16, 17]).
In this context, it is noteworthy that (some) transposable
elements are flanked by short sequence repeats that may
lead to multiplication or deletion of the transposable ele-
ment itself [16, 18].
Rather than ‘passively’ promoting chromosomal alter-
ations, the defining feature of transposable elements is their
ability to translocate to another position in the genome
(Fig. 2c). The mechanisms of transposition differ between
the different elements, and the transposition event may lead
to alterations in the DNA sequence of the donor locus, the
target locus, or both [19, 20]. Notably, transposable ele-
ments seem to vary with respect to their target site
specificity. Whilst some transposable elements seem to
Fig. 2 Types of mutations. Mutations can cause a large variety of
changes in a genome. According to the nature of the change relative to
the ancestral sequence, alterations may be grouped into base substitu-
tions (i.e., transitions and transversions), insertions, deletions,
inversions and translocations. a Examples of the possible effects of a
single nucleotide alteration, including a nucleotide insertion and
deletion, in a coding region. In this figure, the bases constitute codons
and the encoded amino acids are indicated below the DNA sequence to
illustrate possible effects. bExamples of larger-scale alterations. Genes
are depicted as arrows, non-coding regions as bars. c Schematic
representation of a transposition using the Tn5 transposon as an
example. Tn5 is a composite transposon with two flanking IS50
elements and contains multiple resistance genes [125]. A transposase
(encoded by IS50R) mediates excision of Tn5 from the donor locus and
integration into a new location. In the target sequence, Tn5 insertion
leads to duplication of a few base pairs (indicated by asterisk). Note that
transpositionmechanisms differ depending on the transposable element
The outline of figure 2c was taken from [156] with permission
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prefer certain DNA sequences, others, like Tn5, have not
been connected to a specific integration site or sequence
[20, 21].
DNA polymerases
DNA replication is driven by DNA polymerases (DNAPs).
Here, we give an overview of the five different DNAPs in
E. coli and describe their roles in DNA replication and the
occurrence of mutations. We refer to Fijalkowska et al. for
a recent, comprehensive review on the different DNAPs in
E. coli [22].
DNAP III is the main DNAP in E. coli and primarily
responsible for synthesizing the leading and most of the
lagging strand during DNA replication (e.g., [23]). The
polymerase function is confined to the a-subunit of the
enzyme, which is encoded by dnaE [24]. The DNAP III
holoenyzme entails a proofreading function. If a wrong
nucleotide is incorporated, it can immediately be removed
by the 30–50 exonuclease activity of DNAP III. The
exonuclease activity of DNAP III is confined to the e
subunit of the enzyme, which is encoded by dnaQ/mutD
[25]. Mutations in e.g., dnaQ/mutD can considerably pro-
mote mutagenesis in E. coli and have been employed to
facilitate the isolation of protein production strains
[26, 27]. Also, DNAP I, which is encoded by polA, has a
major role during DNA replication (e.g., [22]). DNAP I
degrades RNA primers stemming from lagging-strand
synthesis and re-fills the remaining gaps using the upstream
Okazaki fragment as primer, and also participates in sev-
eral repair pathways (see below). In contrast to DNAP III,
DNAP I is a monomer that combines polymerase activity,
and 30–50 as well as 50–30 exonuclease activities in the same
polypeptide [28–30].
DNAP II is encoded by dinA and combines polymerase
activity and 30–50 exonuclease activity in one protein
[31, 32]. It has been suggested that DNAP II participates in
a variety of processes related to DNA integrity, including
DNA replication under lenient conditions and the general
response to DNA damage, the so-called SOS response
(e.g., [22, 33]). DNAP II is also able to bypass small
lesions in the DNA, thereby maintaining DNA replication
at the risk of promoting mutations (e.g., [34]). This ability
of DNAP II and others has been termed translesion DNA
synthesis [35] and can be essential to keep DNA replication
going when repair pathways either fail to recognize lesions
or if there are too many lesions to be processed [33] (see
below).
The primary role of DNAP IV (encoded by dinB) and
DNAP V (encoded by umuC/D), is to ensure DNA repli-
cation under stressful conditions [33]. However, deletion of
dinB has also been shown to decrease the number of small
frameshift mutations and base substitutions under standard
conditions [36]. Expression of the genes encoding DNAP
IV and V is induced as part of the SOS response [37]. Both
DNAPs are able to bypass certain DNA lesions, and due to
a lack of proofreading activity, DNA synthesis by both
enzymes is essentially error-prone, but to different extents
[38, 39].
Repairing single-strand DNA lesions
In E. coli, the base excision repair (BER), methyl-directed
mismatch repair (MMR), very short patch repair (VSR),
nucleotide excision repair (NER), and transcription-cou-
pled repair (TCR) pathways are all involved in repairing
damage affecting one of the two DNA strands. Mutations
in several of the involved factors (see below) have been
associated with mutator phenotypes, thus illustrating their
importance for maintaining DNA integrity [40]. In this
section, we will give a brief overview of the most basic
features of these DNA repair pathways. To do justice to the
impressive body of work in this area, we will point the
reader to some excellent reviews for further information.
Small chemical alterations of bases, like oxidation,
deamination, alkylation, or abasic sites resulting from
hydrolysis of theN-glycosidic bond between the base and the
sugar moiety, are recognized and repaired by the BER sys-
tem [41] (Fig. 3a). Thesemodifications are part of the natural
decay of DNA, but their occurrence is increased by e.g., the
addition of a variety of chemicals and UV radiation (e.g.,
[42]). If unrepaired, these modifications can impact repli-
cation fidelity; e.g., oxidation of guanine yields 7,8-dihydro-
8-oxoguanine (8-oxoG) that most commonly mis-pairs with
adenine, resulting in a G:C to T:A transversion [41, 43, 44].
E. coli possesses several DNA glycosylases that recognize
altered bases and mediate their removal from the DNA,
thereby creating an abasic site [44, 45]. Enzymes with
apurinic/apyrimidinic (AP)-endonuclease activity mediate
the release of the remaining deoxyribose-phosphate moiety
and the remaining gap is filled and subsequently sealed by
DNAP I and DNA ligase [41, 42, 46].
The MMR system can recognize mis-paired bases
directly upon replication, and short loops of non-matching
nucleotides [47] (Fig. 3b). The methylation state of the
DNA allows the MMR system to distinguish the newly
synthesized DNA strand from the template DNA, since
adenines in the symmetric sequence GATC/CTAG are
methylated by the Dam methylase but remain temporarily
non-methylated in the newly synthesized DNA strand [48].
Briefly, non-matching nucleotides or small indels cause a
distortion, which is recognized and bound by MutS. Sub-
sequently, MutL and MutH are recruited and the
endonuclease MutH incises the most nearby,
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hemimethylated GATC sequence on the newly synthesized
strand [49, 50]. Exonucleases then degrade the strand in
both the 50 and 30 directions, and DNAP III fills the
resulting gap [51–54]. Consistent with the role in DNA
repair, strains deficient in components of the MMR system
show enhanced mutation rates [55–57].
MutS and MutL are not only involved in general mis-
match repair; they are also involved in VSR-mediated
repair [58, 59]. The VSR system acts specifically on T:G
mismatches that result from spontaneous deamination of
5-methylcytosine to thymine. Indeed, 5-methylcytosine has
been shown to be a hotspot for C:G to T:A transition
mutations [60]. To prevent propagation of the error and to
restore the original cytosine, thymine removal is catalysed
by the Vsr endonuclease [61]. The remaining gap is filled
by DNAP I and DNA ligase (e.g., [58, 59, 62]).
The NER system has been shown to be active on a wide
range of DNA lesions that distort DNA, e.g., UV-induced
pyrimidine dimers, chemically modified bases, and, pos-
sibly, cross-links [63–65] (Fig. 3c). Upon recognition of
the lesion by UvrAB, UvrC performs incisions 30 and 50
from the lesion. Subsequently, UvrD promotes dissociation
of the contained nucleotides, and DNAP I re-synthesizes
the excised sequence.
The TCR system removes lesions that hinder progres-
sion of the E. coli RNAP complex [65–67]. Briefly, upon
RNAP stalling, recruitment of the transcription repair
coupling factor, Mfd, leads to clearance of the RNAP
complex from the lesion, primarily by fostering continued
elongation [68]. Subsequently, components of the NER
system are recruited to the lesion and repair it. Whilst the
NER system acts on lesions on both DNA strands, TCR is
Fig. 3 Repair of single-strand DNA lesions. Schematic representa-
tions of the modus operandi of base excision repair (BER) (a),
methyl-directed mismatch repair (MMR) (b) and nucleotide excision
repair (NER) (c). The lesions in the figure serve merely as examples
as the aforementioned repair pathways are capable of repairing a
variety of different lesions. In all examples, bases are shown as blocks
using the one-letter code, the deoxyribose-phosphate moiety is
depicted as a grey line. Incisions are indicated by black triangles
penetrating the sugar–phosphate backbone. a Example of BER acting
on a chemically altered base (denoted by the yellow star). The
affected nucleotide is removed by the subsequent action of a
glycosylase and an AP-endonuclease. DNAP I re-synthesizes the
missing part of the DNA strand and DNA ligase closes the nick.
b Example of MMR acting on a wrongly incorporated adenine (in
yellow). MutS binds to the site of the distortion and subsequently
recruits MutL and MutH. MutH incises the newly synthesized, non-
methylated strand at the sequence GATC. Subsequently, a DNA
helicase and exonuclease unwind and degrade part of the newly
synthesized strand, including the non-matching nucleotide(s). DNAP
III and DNA ligase fill in the missing sequence. c Example of NER
acting on a pyrimidine dimer (in yellow). The UvrAB-complex binds
to the site of the lesion and promotes incisions 30 and 50 from the
lesion by UvrC. Subsequently, the UvrD-helicase promotes dissoci-
ation of the contained stretch of DNA. Also in NER, DNAP I re-
synthesizes the missing part of the DNA strand, and DNA ligase
closes the nick
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thought to foster template strand repair upon transcription
[68].
Apart from the above-mentioned repair pathways,
E. coli has several enzymes at its disposal that directly
reverse chemical alterations, like the photolyase PhrP that
resolves pyrimidine dimers, the triphosphatase MutT that
catalyses the conversion of 8-oxoGTP to 8-oxoGMP, or
methyltransferases that take over methyl groups from
alkylated bases [69–71].
Recombination-dependent repair
In addition to the above-described lesions, E. coli can
repair double-strand DNA breaks and single-strand
DNA gaps [72]. DsDNA breaks can result from e.g., stal-
led replication forks at unrepaired ssDNA lesions, and
single-strand gaps can result from e.g., exposure to ionizing
radiation and UV light.
Repair of dsDNA breaks relies on the presence of a
homologous DNA sequence and the recombinase RecA
(Fig. 4). First, starting from the point of the ds break, the
RecBCD complex mediates unwinding of the DNA and
degradation of the ssDNA strands. Specific motifs in the
DNA, termed CHI-sites, alter the nucleolytic activity of
the complex such that a 30 ssDNA overhang is created
[73, 74]. RecA forms a nucleoprotofilament at the 30
overhang and mediates homology searching and strand
invasion at a homologous double strand. Templated by the
homologous DNA, replication re-starts and the missing
sequences are filled in, followed by resolution of the
resulting Holliday junctions. Just as the repair of dsDNA
breaks, also post-replication repair of ssDNA gaps
requires RecA-mediated strand invasion, templated DNA-
synthesis and resolution. However, the initial steps are
catalysed by RecFOR rather than RecBCD [75]. For
detailed information on the players and steps involved in
the repair of dsDNA breaks and ssDNA gaps, see e.g.,
[76–78]. Finally, RecA, together with components of the
NER pathway, has been implicated in the repair of DNA
lesions in ssDNA regions [79].
Global response regulators and other factors
affecting mutability
Throughout the previous sections, we focused on individ-
ual components and systems involved in DNA replication
and repair. Importantly, all these components and systems
are part of global networks that can affect mutagenesis in
E. coli at a given condition (e.g., [77]). The number of
mutations that accumulates in a strain within a defined
period of time is commonly referred to as its mutation rate
and depends on the selection conditions used. Mutation
rates observed under conditions with minimal selection are
referred to as baseline or spontaneous mutation rates.
Recently, the Foster laboratory determined the spontaneous
mutation rate for E. coli at 0.87 9 10-3 nucleotides per
genome per generation [56]. This number includes base
substitution mutations and small indels of four or less
nucleotides, which constituted the vast majority of the
changes observed. However, adverse conditions, like
nutrient deprivation, the presence of antibiotics, exposure
to certain chemicals or temperature fluctuations, can elicit
Fig. 4 Recombination-dependent repair of double-strand breaks. The
RecBCD complex has both helicase and nuclease activity. It unwinds
the DNA starting from the site of the break and degrades both strands
during this process. Movement of RecBCD along the DNA is
indicated with an arrow. At specific sites (indicated by ‘x’), the
activity of the complex is altered such that only the strand with the
free 50 end continues to be degraded. That way, a 30 overhang is
created. RecA forms a nucleoprotofilament at the 30 overhang and
promotes strand invasion at a homologous double strand. Templated
by the homologous DNA, replication re-starts and the missing
sequences are filled in, followed by resolution of the resulting
Holliday junctions. For the sake of clarity, proteins are only depicted
on one site of the double-strand break
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(global) responses that can lead to an increase in the
accumulation of mutations [37].
One of the best characterized global responses in E. coli
that can affect the mutation rate is the SOS response (e.g.,
[77, 80, 81]). This response is invoked by lesions in the
DNA that hinder replication and result in ssDNA stretches,
and coordinates expression of many of the above-men-
tioned genes (e.g., [82, 83]). Briefly, under standard
conditions, the repressor LexA prevents transcription of
these genes by binding to a specific sequence (the SOS
box) in their operator region. ssDNA stretches are bound
by the recombinase RecA, which then stimulates self-
cleavage of LexA. Upon self-cleavage, LexA dissociates
from the SOS box, allowing transcription of the SOS genes
and, subsequently, DNA repair. Importantly, the SOS
response appears to be precisely timed, and coordinated
and fine-tuned by a multitude of mechanisms including the
aforementioned transcriptional regulation and diverse post-
translational mechanisms and interactions, presumably to
avoid excessive mutations (e.g., [77, 84–87]).
The RpoS response has also emerged as a key modu-
lator of the evolution of E. coli. The alternative sigma
factor RpoS governs the general stress response and has
been proposed to affect the expression levels of more than
200 genes, including mutS and mutH (e.g., [88–90]). RpoS
deficiency results in decreased levels of DNAP IV in sta-
tionary phase E. coli cells, indicating a role of DNAP IV in
the starvation response [91]. Interestingly, it has been
shown that e.g., b-lactam antibiotics can lead to an increase
of mutation rates and alter the mutation pattern in an RpoS-
dependent manner, likely owing to increased levels of the
DNAP IV with a concomitant decrease in MutS levels [92].
Recently, the Ferenci laboratory showed that varying RpoS
levels gives rise to different mutation rates and patterns.
Increasing the levels of RpoS leads to a decrease of MutS
levels and an increase of DNAP IV levels and vice versa
[90, 92, 93]. These observations are highly relevant for the
isolation of strains with improved protein production
characteristics, since, during their isolation, cells are
exposed to stress caused by the production of proteins.
Apart from the above-mentioned global regulators,
molecular chaperones can also affect mutagenesis during
the evolution of E. coli strains [94–96]. Indeed, several
lines of evidence indicate that molecular chaperones can
actually buffer mutations that compromise protein structure
and function [96, 97]. It has been shown that e.g., levels of
the molecular chaperones GroEL and DnaK are increased
in E. coli strains with elevated mutation rates. In keeping
with previous observations [97], expression of groEL
mitigated the growth defects in mutated strains but had no
effect on their ancestor [96]. Recently, it has been shown
that RNA chaperones can also act as mutation buffers for
mutations affecting RNA structure [94].
E. coli as a platform for the production
of recombinant proteins
Escherichia coli is the most widely used host to produce
recombinant proteins. However, E. coli-based protein
production can be hampered at many different levels.
It has been shown that the efficient production of pro-
teins can be hampered by e.g., inefficient binding of the
mRNA encoding the target protein to the ribosome, insta-
bility of the mRNA, secondary structures in the mRNA and
non-optimal codon usage. These problems can usually be
solved by modifying the target gene and its flanking
regions in the expression vector [2, 98]. Protein production
can also be hampered by metabolic stress (e.g., [99–102]).
This will negatively affect biomass formation and, conse-
quently, may result in insufficient production yields. It has
been shown that biomass formation can be improved by
e.g., changing culture and/or target gene expression con-
ditions as well as metabolic engineering (e.g., [2, 103]).
The production of sufficient amounts of functional protein
can also be hampered by e.g., misfolding, degradation and
mistargeting of the target protein [104]. There are exam-
ples where deleting genes encoding proteases, or
overexpressing genes encoding molecular chaperones or
targeting factors have led to improved protein production
yields (e.g., [105–108]). Ideally, such engineering approa-
ches to improve the production of a protein are based on
detailed knowledge of what hampers its production.
Unfortunately, it is usually not known what hampers the
production of a protein. Therefore, engineering approaches
are also used in combination with trial-and-error-based
protein production screening exercises. However, to iden-
tify a strain with improved protein production
characteristics, this way is often not successful.
When sufficient knowledge to engineer a strain with
improved protein production characteristics is lacking, one
could try to isolate such a strain using evolutionary
approaches, i.e., by selecting or screening for a genetically
altered strain with improved production characteristics. So
far, evolutionary approaches have only been used on a very
limited scale to isolate E. coli mutants with improved
protein production characteristics. However, they have
been widely and successfully used to modulate metabolic
pathways in E. coli for metabolite production (e.g.,
[109–111]). This indicates that the use of evolutionary
approaches to isolate E. coli protein production strains may
actually have more potential than currently appreciated.
In a selection, conditions are used in which only the
desired mutant can multiply or its multiplication is at least
strongly favored [4]. In contrast, in a screen, a large
number of bacteria are examined under non-selective
conditions to identify the strain with the desired
Isolating Escherichia coli strains for recombinant protein production 897
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characteristics [4, 112]. Both approaches rely on mutations,
and as described above and summarized in Fig. 5, mutation
rates and spectra and, thus, the outcome of the isolation,
can be affected by a variety of different factors.
In the following sections, we will discuss the, in our
view, most relevant examples of the isolation of evolved
E. coli strains with improved protein production charac-
teristics. We will first focus on approaches that employed
mutagenic agents, mutator genes or transposons to facili-
tate mutagenesis. Subsequently, we will discuss isolation
strategies relying on spontaneous mutations. Finally, we
will discuss how evolutionary approaches may be used in
the future to isolate E. coli protein production strains.
Evolving protein production strains using mutagenic
agents and mutator genes
To evolve strains with improved membrane protein pro-
duction characteristics, the Bowie laboratory used an elegant
selection-based approach [27]. The aim was to produce tar-
get membrane proteins in the cytoplasmic membrane rather
than in inclusion bodies, since it is relatively easy to isolate
membrane proteins from a membrane system compared to
isolating them from inclusion bodies [113]. It should be
noted that when a membrane protein is inserted into a
membrane system, it does not necessarily mean it is properly
folded and functional. The gene encoding the membrane
protein of interest was cloned in two compatible expression
plasmids. Each plasmid was constructed such that the
membrane protein was C-terminally fused to an antibiotic
resistance marker conferring resistance to trimethoprim
(plasmid 1) or kanamycin (plasmid 2). This way, an
increased resistance to the two antibiotics could be used as a
direct indicator for elevated levels of the target protein
inserted in the cytoplasmic membrane.
To introduce (chromosomal) mutations, cells containing
plasmid 1 were either exposed to the mutagenic base analog
2-aminopurine (AP2), which is an adenine analog that can
miss-pair occasionally with cytosine, or they were trans-
formed with an expression plasmid containing the mutator
gene mutD5, which encodes a variant of the e subunit of
DNAP III that is deficient in 30–50 exonuclease activity [114].
Subsequently, mutant strains with increased resistance
towards trimethoprim were selected for. Positive candidates
were then transformed with plasmid 2 and probed for
increased resistance towards kanamycin. Importantly, the
use of a dual selection strategy considerably lowered the risk
of obtaining unrelated mutations that confer resistance to
both antibiotics without increasing membrane protein pro-
duction yields. Several mutant strains that produced elevated
levels of the target membrane proteins were isolated. Inter-
estingly, these strains differed widely in their ability to
producemembrane proteins other than the target used during
their isolation. Unfortunately, these strains have never been
characterized in detail, and the mutations underlying their
phenotypes are still unknown. Given that the mutation rates
were increased using a base analog or a mutator gene, it is
very well possible that such an analysis would be compli-
cated due to the presence of non-related mutations. Indeed,
the authors reported a 300-fold increase in mutation rates
over background upon using the mutD5 allele. It should be
noted that one of the isolated strains showed a reduced copy
number of the expression plasmids used. It has been specu-
lated that the reduced plasmid copy number may lead to
lowered target gene expression intensity, thereby improving
membrane protein production yields in the cytoplasmic
membrane [115].
The Georgiou laboratory employed chemical mutagen-
esis to generate E. coli mutants that efficiently produce
properly assembled full-length IgG antibodies in the peri-
plasm [116]. The periplasm is the preferred compartment
of the E. coli cell to produce disulfide bond-containing
proteins like IgG antibodies. In contrast to the reducing
cytoplasm, disulfide bonds can be stably formed in the
Fig. 5 Factors affecting
mutation rates and patterns.
Schematic representation of
how extrinsic and intrinsic
factors may contribute to the
observed mutation rates and
patterns. Screening for or
selection of a certain phenotype
is based on the acquired
mutations
898 S. Schlegel et al.
123
periplasm due to the presence of DsbA and DsbB [117].
The periplasmic protein DsbA harbours a thioredoxin
domain and acts as oxidizing agent (electron-acceptor) for
the disulfide bond-forming cysteines of the target protein.
The cytoplasmic membrane protein DsbB receives elec-
trons from DsbA and transfers them to quinones in the
cytoplasmic membrane, thereby maintaining DsbA in an
active state. Cells harbouring an IgG expression plasmid
were treated with the alkylating agent N-methyl-N’-nitro-
N-nitrosoguanidine (MNNG), and clones with increased
levels of functional IgG were isolated using a small, fluo-
rescent IgG antigen and repeated rounds of fluorescence-
activated cell sorting (FACS). Note that MNNG mainly
methylates guanines at the O6 position. The resulting O6-
methylguanine base pairs with thymine during DNA
replication, which may result in a G:C to A:T transition
[118]. Using this approach, the authors isolated several
clones that were markedly improved in their ability to
produce IgGs. Also here, the defining mutations were not
identified. In this respect, it should be noted that MNNG
can increase the mutation frequency several hundred fold
above background level [119]. Therefore, it is possible that
the isolated strains have acquired both beneficial and
deleterious mutations in multiple loci, which might hinder
identifying the mutations responsible for the improved
production of IgG. Moreover, the ancestral strain was
deficient in the recombinase RecA, one of the major
players in recombination-dependent DNA repair. Indeed,
most of the isolated clones were excluded from further
studies due to growth defects, indicating the accumulation
of deleterious mutations.
Recently, Hatahet et al. isolated E. coli mutant strains
that efficiently produce a variant of the mammalian poly-
topic membrane protein vitamin K epoxide reductase
(VKORc1) [120]. Mammalian VKORc1 maintains thiore-
doxin-like proteins in an oxidized state by transferring
electrons to membrane-bound quinones, analogous to the
previously described DsbB. Despite these functional
analogies, mammalian VKORc1 could not restore motility
of an E. coli strain lacking dsbB. In E. coli, DsbB is critical
to mediate an essential structural disulfide bond in FlgI, a
major component of the flagella machinery [121]. There-
fore, first, a VKORc1 variant that is functionally produced
in E. coli was isolated. To this end, a mutagenized vkorc1
expression plasmid library was created using the mutator
strain XL1-Red [122]. This strain contains the aforemen-
tioned mutD5 allele and is deficient in both MutS, which is
involved in several DNA repair pathways, and MutT,
which counteracts replication errors that may arise from the
oxidation of guanine (see above). Using the mutagenized
expression library, functional VKORc1 variants
(mtVKORc1) were selected for based on their ability to
(partially) restore motility of a strain lacking dsbB.
Since the isolated mtVKORc1s only partially restored
the ability to form disulfide bonds in the DsbB-deficient
strain, strains with improved mtVKORc1 production
characteristics were isolated. E. coli cells were treated with
the mutagenic agent ethyl methanesulfonate (EMS) to
facilitate mutagenesis [114]. Similar to the aforementioned
mutagenic agent MNNG, EMS preferentially alkylates
guanine at the O6 position which can result in G:C to A:T
transitions. From the treated cells, mutants with improved
production levels for one of the mtVKORc1s were selected
on plates containing the disulfide-breaking agent, Tris
2-carboxyethyl phosphine, that prevents growth of strains
deficient in disulfide bond formation. In the isolated clones,
disulfide bond formation, i.e., production levels of func-
tional mtVKORc1, was subsequently probed using
different phenotypic screens.
Sequencing of 11 strains that produced increased levels
of functional mtVKORc1 revealed that they had accumu-
lated multiple mutations in different locations. However,
seven out of the eleven isolated strains had acquired a non-
synonymous base substitution in the gene encoding the
membrane insertase/foldase YidC, indicating a potential
benefit. Indeed, three out of the four different mutations led
to a roughly fourfold increase of the levels of functional
mtVKORc1. Interestingly, two of the mutations that
increased mtVKORc1 yields resulted in an amino acid
exchange in the hydrophilic groove of YidC, which is the
part of the membrane-integral portion of the protein that
has been implicated in substrate binding [123]. This led the
authors to suggest that, at least in the case of these muta-
tions, higher functional yields of mtVKORc1 may be
attributed to a more relaxed YidC substrate binding
specificity. Besides the mutations in yidC, also mutations
inactivating HslV, the protease subunit of the cytoplasmic
HslUV complex, were identified and shown to enhance
production yields of both mtVKORc1 and VKORc1, pos-
sibly by preventing their premature degradation in the
cytoplasm. However, activity increased only for
mtVKORc1, highlighting the need to monitor protein
activity when improving protein production yields.
Combining proteolytically inactive HslV with mutated
YidC further improved the functional yields of
mtVKORc1. Using a yidC mutant strain also decreased
toxicity of proteorhodopsin production was observed [120].
However, deletion of hslV had the opposite effect, illus-
trating that the outcome of a genetic alteration can be
highly context-dependent.
Transposon mutagenesis
Also, transposon mutagenesis has been used to isolate
strains with improved protein production characteristics. It
should be kept in mind that the nature of mutations caused
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by transposons is different than the ones caused by muta-
genic agents and mutator genes, although the effect can be
similar [40]. Insertion of a transposon in the vicinity of a
gene can affect its expression levels, and insertion into an
intact gene may result in complete loss of function or lead
to the synthesis of a truncated variant of the encoded
protein, thereby affecting its function. However, in contrast
to approaches based on mutagenic agents and mutator
genes, identifying the loci targeted by a transposon is rel-
atively straightforward, which facilitates identifying the
genetic basis of the improvement [20, 21, 112].
The Georgiou laboratory used Tn5 transposon mutage-
nesis to isolate E. coli variants that produce increased
amounts of the human GPCR central cannabinoid receptor
(CB1) in the cytoplasmic membrane [124]. Due to a lack of
any noticeable insertion sequence preference, Tn5 is a
widely used mobile element for approaches relying on
transposon mutagenesis [125]. To monitor CB1 production
levels in the cytoplasmic membrane, the protein was fused
to green fluorescent protein (GFP) [126]. This enabled
enriching the cells with improved CB1–GFP production
characteristics from a pool of Tn5 insertion mutants using
FACS. Subsequently, single clones were isolated and the
site of Tn5 insertion was determined. The most pronounced
improvement in CB1–GFP accumulation levels, as well as
in biomass formation, was found to be due to a Tn5
insertion in the gene encoding DnaJ, which is a co-chap-
erone that is part of the DnaK/DnaJ/GrpE chaperone
system [127]. Interestingly, Tn5::dnaJ did not improve the
production of any of the other GPCRs tested. Thus,
Tn5::dnaJ specifically improved CB1 production, and
furthermore, the improvement did not depend on the
presence of the GFP moiety. To explain the observed
phenotype, the authors hypothesized that the absence of
DnaJ may either increase the efficiency at which CB1 is
targeted to the membrane or, alternatively, prevent the
DnaK/DnaJ-mediated degradation of CB1. However, it is
also possible that the effects of Tn5::dnaJ are considerably
more pleiotropic and even influenced by the temperature
shift from 37 to 12 C during the production of CB1. In
mutants carrying a defective dnaJ allele, the heat-shock
response is continuously ON, due to impaired regulation of
the heat-shock sigma factor r32 [128]. DnaJ has been
shown to interfere with lon-mediated degradation of
secretory proteins, and the absence of dnaJ has been sug-
gested to delay ribosome biosynthesis [129, 130]. All this
makes that it may be very difficult to elucidate how dnaJ
mutations improve the production of CB1.
Escherichia coli naturally secretes the YebF protein into
the extracellular medium and it has successfully been used
as a fusion partner for the production of recombinant
proteins in the extracellular medium [131, 132]. Haitjema
et al. used Tn5 transposon mutagenesis to isolate mutants
with improved secretion characteristics for YebF/YebF
fusion proteins [133]. To rapidly screen for such mutants, a
fluorescence-based assay enabling to specifically detect
YebF secreted into the extracellular medium was used.
Eight different gene insertions leading to improved secre-
tion of YebF/YebF fusion proteins into the extracellular
medium were isolated. For two mutants, one with the envZ
gene and the other with the ompR gene disrupted by Tn5, it
was shown that the cell envelope was less stable, pre-
sumably leading to the leakage of proteins into the
extracellular medium. For the remaining six mutations, the
mechanism leading to enhanced secretion of YebF/YebF
fusion proteins into the extracellular medium remains
speculative.
Finally, Tn5 transposon mutagenesis was also used to
isolate E. coli variants that produce increased amounts of
signal recognition particle (SRP)-targeting pathway-de-
pendent secretory proteins and membrane proteins in the
periplasm and cytoplasmic membrane, respectively [134].
In E. coli, the SRP-targeting pathway guides a subset of
secretory proteins and most membrane proteins, in a co-
translational fashion, to the protein conducting Sec-
translocon in the cytoplasmic membrane [135]. To allow
rapid screening of a Tn5 transposon-insertion library for
clones with improved protein production characteristics,
the authors used a fluorescence-based assay to monitor
protein production in the periplasm. In all analysed
mutants, Tn5 had disrupted the rrsE gene, which is one of
the seven gene copies in E. coli encoding the 16S rRNA.
The rrsE deficiency was shown to improve the periplasmic
production of proteins secreted via the SRP-targeting
pathway and the production of membrane proteins in the
cytoplasmic membrane. The underlying mechanism for this
improvement is yet unknown. Notably, it was shown that
the rrsE deficiency not only leads to increased production
yields in standard batch cultures, but also in high cell
density fermentations.
Isolation of protein production strains
without facilitating mutagenesis
On a limited scale, strains with improved protein produc-
tion characteristics have also been isolated without
facilitating mutagenesis. Nevertheless, the procedures used
to isolate these strains may very well have affected muta-
tion rates and patterns (Fig. 5). Probably, the best known
examples of protein production strains isolated without
facilitating mutagenesis are the BL21(DE3)-derived
C41(DE3) and C43(DE3) strains [136]. We will first dis-
cuss their isolation and then give an overview of the other
reported examples.
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The isolation of C41(DE3) and C43(DE3)
C41(DE3) was isolated from the common protein produc-
tion strain BL21(DE3), and C43(DE3) was subsequently
isolated from C41(DE3) [136]. In BL21(DE3), expression
of the gene encoding the target protein is driven by bac-
teriophage T7 RNA polymerase (P), which transcribes
eight times faster than E. coli RNAP [137–139]. T7 RNAP
specifically recognizes the T7 promoter, which drives the
expression of the target gene from a plasmid [137, 139].
The gene encoding the T7 RNAP is under control of the
lacUV5 promoter region (PlacUV5), which is a strong, car-
bon-catabolite repression protein (CRP)–cAMP
independent variant of the wild-type lac promoter region
(PlacWT) [140, 141]. Note that we chose the term ‘region’ to
incorporate sequence differences observed in the CRP–
cAMP binding site and the O1 operator site in BL21(DE3).
The addition of isopropyl-b-D-thiogalactopyranoside
(IPTG) leads to the production of T7 RNAP and, conse-
quently, expression of the target gene. Expression of genes
encoding recombinant proteins is often toxic to
BL21(DE3), resulting in poor growth and low protein
production yields. Major reasons for this toxicity appear to
be the saturation of protein biogenesis pathways and
metabolic stress (e.g., [100, 101]).
To isolate C41(DE3), BL21(DE3) was transformed with
a T7-based expression vector harbouring the gene encoding
the mitochondrial oxoglutarate malate carrier protein
(OGCP) [136] (Fig. 6). Expression of ogcp, which is highly
toxic, was induced with IPTG, and surviving cells were
selected for, on IPTG-containing agar plates. Thus, toxicity
of ogcp expression served as selective agent. In a second
step, IPTG-resistant clones that efficiently produced OGCP
were cured from the ogcp expression plasmid by culturing
them for a prolonged period of time in a closed setup. This
led to the isolation of C41(DE3), which not only can effi-
ciently produce OGCP but also many other proteins whose
production is toxic to BL21(DE3). Recently, it was shown
that three single nucleotide polymorphisms (SNPs) in
PlacUV5 are solely responsible for the improved protein
production characteristics of C41(DE3) [101, 142, 143].
The three SNPs specifically change the -10 region and the
O1-operator/?1 site of PlacUV5 to PlacWT (Fig. 7). This
weakens the promoter region, resulting in reduced t7rnap-
and, consequently, target gene expression levels upon
addition of IPTG. Notably, the promoter region governing
t7rnap expression in C41(DE3) appears not only to be
weaker than PlacUV5 but also weaker than PlacWT and was,
therefore denoted PlacWeak [143]. Although, in first
instance, counterintuitive, reduced target gene expression
levels result for many target proteins in higher protein
production yields, because the overloading of the protein
biogenesis machinery as well as metabolic stress are
reduced [101, 144].
A pivotal experiment in the identification of the defining
mutations of C41(DE3) was the reconstruction of its iso-
lation from BL21(DE3) in real time [143]. This approach
revealed that BL21(DE3) derivatives harbouring the same
three SNPs in PlacUV5 as C41(DE3) could be isolated
within only a couple of hours after the transformation of
the ogcp expression vector into BL21(DE3). Both the
speed of the occurrence of the mutations in PlacUV5 and
their specific nature could be best explained by homolo-
gous recombination between PlacUV5 and PlacWT that is part
of the lac operon present in BL21(DE3). Recombination is
most likely facilitated by the presence of sizable DNA
sequences around PlacUV5 governing t7rnap expression that
are homologous to the ones flanking PlacWT in the lac
operon. Indeed, mutations in PlacUV5 did not occur in
BL21(DE3) derivatives that are recA-deficient or lack
PlacWT in the lac operon. Using expression vectors con-
taining genes encoding target proteins other than OGCP
gave similar results, and for some targets, even BL21(DE3)
derivatives with a complete conversion of PlacUV5 to PlacWT
Fig. 6 Isolation of C41(DE3) from BL21(DE3). To isolate
C41(DE3), BL21(DE3) was first transformed with a T7-based
expression vector harbouring the gene encoding the mitochondrial
oxoglutarate malate carrier protein (OGCP) and expression of ogcp
was induced with IPTG in liquid culture. Notably, the ogcp
expression vector has an ampicillin resistance marker. Surviving
cells were selected for on IPTG-containing agar plates and subse-
quently probed for efficient OGCP production. In a second step,
selected clones were cured from the ogcp expression vector by
culturing them for a prolonged period of time in a closed setup
(modified after [143])
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were isolated [143]. The accumulation of mutations in
PlacUV5 represents an interesting case of evolutionary trade-
off. On the one hand, they provide an easy and very fast, if
not the fastest possible, escape from the immediate toxicity
of protein production and, therefore, a large, initial growth
benefit. On the other hand, these cells still produce the
target protein, which should reduce their growth relative to
non-producers, and consequently, they may be outcom-
peted by the non-producers over time.
Even though many difficult proteins could be efficiently
produced in C41(DE3), there were some exceptions, like
the subunit b of the E. coli FoF1 ATPase (Ecb) [136]. This
membrane protein was used to isolate C43(DE3) from
C41(DE3) following essentially the same experimental
setup used for the isolation of C41(DE3) from BL21(DE3)
[136]. Mutations in the lac-repressor gene, lacI, adjacent to
the gene encoding the T7 RNAP appear to be key to the
improved protein production characteristics of C43(DE3)
[142]. It has been proposed that these mutations result in a
LacI variant that binds with a higher affinity to the lac
operator site. This is in keeping with lowered T7 RNAP
accumulation levels in C43(DE3) compared to C41(DE3),
and with the delayed onset of the synthesis of the lactose
permease, LacY, in C43(DE3) upon the addition of IPTG
[101]. Interestingly, it seems that the mutations in lacI
could only be selected for when PlacWeak was governing
t7rnap expression [142].
Both C41(DE3) and C43(DE3) acquired additional
mutations during their isolation [142, 143]. The role of
many of these mutations is not clear yet. Some of the
mutations enhance the ability to take up nutrients in
C41(DE3). It has, therefore, been suggested that they can
be attributed to starvation stress imposed during the plas-
mid curing step [143]. It is worth mentioning that five out
of the 12 changes specific for C43(DE3) and one alteration
common to both C41(DE3) and C43(DE3) involve IS-
elements [142, 143]. Since the activity of IS-elements has
been linked to stressful conditions, at least part of the
observed alterations might be a consequence of the
isolation procedures used. It is also worth mentioning that
in C43(DE3), expression of lon is restored [101, 142]. The
Lon protease interferes quite often with the production of
proteins in the cytoplasm and BL21(DE3) is lon-deficient
due to an IS-element inserted in the lon promoter region. In
C43(DE3), lon expression is restored due to the removal of
this IS-element and this could explain why some proteins
are produced less efficiently in C43(DE3) [101, 136, 142]
(see below). However, as observed by Hatahet et al., pro-
tease deficiency not necessarily positively affects the
production of functional protein material and it is very well
possible that the production of some targets benefits from
the restored Lon activity due to an increased turnover of
misfolded/aggregated proteins.
Other examples of the isolation of protein
production strains without facilitating mutagenesis
To the best of our knowledge, so far, four other examples
of the isolation of E. coli strains with improved protein
production characteristics without facilitating mutagenesis
have been reported.
Zhao et al. used a recA-deficient BL21(DE3) derivative
to isolate variants that efficiently produce an engineered,
bispecific single-chain antibody [145]. Similar to the setup
used to isolate C41(DE3) and C43(DE3), cells containing a
T7-based expression vector were spread on agar plate
containing IPTG to select for IPTG-resistant mutants.
Subsequently, the production of the antibody was moni-
tored in the isolated IPTG-resistant mutants. In two of the
mutants, protein production yields were about twofold
higher compared to the yield obtained in their ancestor, and
both mutants showed improved plasmid stability. The
causative mutations have not been identified, but pheno-
typic differences between the two isolates suggest the
presence of distinct or unrelated mutations. It would be
interesting to characterize these isolates in more detail.
Importantly, the use of a recA-deficient strain prevents a
recombination-mediated event weakening PlacUV5. Thus,
Fig. 7 PlacWT, PlacUV5 and PlacWeak. Expression of the lac operon
(lacZYA) is governed by the PlacWT region. A variant of this well-
known promoter region, termed PlacUV5, controls the expression of the
gene encoding T7 RNAP in BL21(DE3) [142]. This variant differs
from PlacWT in four positions (asterisk). For better orientation, we
highlighted the relevant sites: the binding site for CRP–cAMP, the
-35/-10 binding sites for E. coli RNAP, and the first bases of the
O1-operator site. Note that the term region was chosen to account for
all four mutations. In different BL21(DE3)-derived protein produc-
tion strains including C41(DE3) [101, 142, 143, 146], PlacUV5 has
reverted to a weaker variant, designated PlacWeak [143]. This variant
still harbours the altered CRP–cAMP binding site of the PlacUV5
region, but reverted to PlacWT in the -10 and the O1-operator site
Picture was taken from [143] with permission
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these strains most likely have acquired mutations other
than the defining ones in C41(DE3) and C43(DE3).
The Cole laboratory isolated BL21(DE3)-derived
mutants with an improved ability to produce the cyto-
plasmic E. coli protein CheY, which is involved in
chemotaxis [146]. To facilitate monitoring protein pro-
duction levels during the isolation process, CheY was fused
to GFP. Expression of the cheY–gfp fusion was induced
with IPTG, and GFP fluorescence was used to identify
mutants with improved CheY–GFP production character-
istics both on agar plates and using FACS. All mutants with
improved CheY–GFP production yields had acquired the
same mutations in PlacUV5 as C41(DE3). However, at least
one of the mutants likely harboured additional, unidentified
mutations, as CheY–GFP production yields and the frac-
tion of soluble CheY–GFP were higher as compared to
C41(DE3). The neisserial outer membrane lipoprotein Ccp,
which is a cytochrome c peroxidase, could only be pro-
duced to very low levels in this mutant as compared to
C41(DE3) and C43(DE3), strongly indicating that the
effects of any unidentified mutation are target protein-de-
pendent. Interestingly, in C43(DE3), hardly any
cytoplasmic CheY–GFP was produced, whereas functional
yields of the secreted, neisserial target were very high.
These observations may very well be explained by the
restored expression of lon in C43(DE3) (see above). The
performance of isolated strains was also tested in more
industry-scale batch cultures.
Gul et al. isolated several mutants with improved
membrane protein production characteristics [147]. To this
end, two target membrane proteins, the E. coli glutamate
transporter GltP and the Lactococcus lactis amino acid
permease BcaP, were used. The two targets were fused to
both GFP, enabling monitoring the accumulation levels of
the target protein in the cytoplasmic membrane, and EmrC,
conferring resistance to erythromycin. Mutant strains were
selected for by gradually increasing the erythromycin
concentration in the culture medium. GFP fluorescence was
used to monitor if increased erythromycin resistance also
led to increased membrane protein production yields in the
cytoplasmic membrane. Besides few other mutations, all
isolated strains had acquired at least one mutation in the
hns gene. In general, the parallel isolation of mutations in
the same gene can be a first indicator for a correlation to
the obtained phenotype. However, H-NS is a DNA-binding
protein implicated in transcriptional repression (silencing)
as well as in bacterial chromosome organization [148].
Notably, the isolated mutants varied in their ability to
efficiently produce different target proteins, and data
shown for at least one of the isolated strains suggest the
presence of mutations specific towards the target protein
used during the isolation. Given the broad range of effects
that mutations in hns may cause and the potential
contributions from other mutations, it remains unclear why
the isolated strains have improved membrane protein pro-
duction characteristics.
The Beckwith laboratory used a combination of evolu-
tionary approaches and directed engineering to create
strains enabling the efficient production of disulfide-con-
taining proteins in the cytoplasm [149] (Fig. 8). Notably,
the initial aim was not to isolate protein production strains,
but rather to investigate the mechanisms that prevent the
stable formation of disulfide bonds in the cytoplasm. For
that purpose, a screening approach was used to isolate
E. coli strains that allow the formation of disulfide bonds in
the cytoplasm [150]. In the screen, PhoA, a periplasmic
protein which requires disulfide bonds for its activity, was
produced without a signal sequence in a strain lacking the
chromosomal copy of phoA. The activity of the signal-
sequence-less PhoA served as an indicator for cytoplasmic
disulfide bond formation. Subsequently, mutants with
PhoA activity were screened for, which resulted in the
isolation of trxB-deficient strains. TrxB encodes a thiore-
doxin reductase that serves as reducing agent for the two
thioredoxins TrxA and TrxC. In a trxB-deficient mutant,
the two E. coli thioredoxins TrxA and TrxC remain in an
oxidized state and can catalyse the formation of disulfide
bonds in the cytoplasm. Later on, disulfide bond formation
was found to be even more efficient in trxB null mutants
that were unable to either synthesize or reduce gluthathione
(gshA or gor). However, these double mutants grow very
poorly and require an exogenous reductant such as DTT to
achieve a reasonable growth rate [151]. Finally, to cir-
cumvent the growth defect, suppressor strains were isolated
that grow well and still allow stable disulfide bond for-
mation in the cytoplasm [152]. These strains have been
widely used to produce disulfide bond-containing recom-
binant proteins. Production yields can be further improved
by expressing the gene encoding a disulfide bond isomerase
in the cytoplasm [152].
Concluding remarks
There is only a limited number of examples of E. coli
strains with improved protein production characteristics
isolated by evolutionary approaches. Interestingly, using
evolutionary approaches to modulate metabolic pathways
in E. coli for metabolite production has been very suc-
cessful [110, 111]. This appears to be due to the relative
ease to monitor most metabolites. Therefore, it is not sur-
prising that the major bottleneck hampering the use of
evolutionary approaches to isolate E. coli protein produc-
tion strains seems to be the ability to rapidly and accurately
monitor not only the amount, but also the quality of a
produced protein. The importance of being able to monitor
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both protein quantity and quality is nicely illustrated by the
isolation of strains with improved IgG and mtVKORc1
production characteristics [116, 120]. We reckon that the
development of, in many instances target-specific, assays
to rapidly monitor protein production will be key for
extending the use of evolutionary approaches to isolate
E. coli protein production strains.
In all the reported examples of the isolation of E. coli
protein production strains, different strain backgrounds,
promoter systems, induction regimes, culturing conditions
and, sometimes, also ways to facilitate mutagenesis were
used. This makes that it is currently impossible to formu-
late general rules for how to design an experiment to isolate
an E. coli protein production strain. So far, it appears that
the effects that most of the aforementioned factors can have
on the isolation of protein production strains may have
been underestimated. One obvious example is the isolation
of C41(DE3) from BL21(DE3), which depended on the
presence of the native lac wild-type promoter and RecA in
the ancestor strain BL21(DE3). However, also more subtle
factors like the induction kinetics of a chosen promoter
system or varying levels of global regulators in different
strain backgrounds may influence the evolutionary trajec-
tories of protein production strains. Also, stress caused by
e.g., starvation, temperature fluctuations, and exposure to
antibiotics during the strain isolation procedure may affect
evolutionary trajectories [37]. Therefore, accumulated
mutations in an isolated protein production strain may not
only reflect adaptations improving protein production. The
presence of the same or similar mutations in multiple,
parallel isolated strains may help to identify the key
mutations for improving protein production or simply
reflect the isolation conditions used [120, 136, 142, 143].
Incorporating temporal resolution, or evolving strains in
parallel without the expression plasmid or with an empty
expression plasmid may aid in discerning the accumulated
mutations. It might also be interesting to see how the
ability to fine-tune mutation rates and patterns could affect
the isolation of protein production strains [153]. Finally,
newly developed evolutionary approaches that enable to
randomly alter specific loci like multiplex automated
genomic engineering (MAGE) have been successfully used
to isolate E. coli strains for metabolite production [154].
Recently, it was also used to create a strain for the efficient
production of a protein containing multiple non-natural
amino acids [155]. The ability to efficiently mutate defined
regions in the genome may make MAGE a very powerful
tool to isolate protein production strains, in particular ones
where one already knows what components, e.g., molecular
chaperones and protein targeting factors, or even parts
thereof to target.
Surprisingly, there are only two reported examples of
evolved protein production strains whose performance was
also tested in a culturing setup resembling one often used in
Fig. 8 Combining evolutionary approaches and engineering to create
E. coli strains enabling the efficient production of disulfide-containing
proteins in the cytoplasm. A screening approach was used to isolate
E. coli strains that allow the formation of disulfide bonds in the
cytoplasm [150]. In the screen, PhoA, a periplasmic protein, which
requires disulfide bonds for its activity, was produced without a signal
sequence in a strain lacking chromosomal phoA. The activity of the
signal-sequence-less PhoA served as an indicator for cytoplasmic
disulfide bond formation. Subsequently, mutants with PhoA activity
were screened for, which resulted in the isolation of trxB-deficient
strains. Using an engineering approach, it was found that disulfide
bond formation in the cytoplasm is even more efficient in trxB null
mutants that are unable to either synthesize or reduce gluthathione
(gshA- or gor-) [151]. However, these double mutants grow very
poorly and require an exogenous reductant to achieve a reasonable
growth rate. Finally, suppressor strains were isolated that grow well
and still allow stable disulfide bond formation in the cytoplasm [152]
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industry [134, 146]. If an E. coli protein production strain
performs well in small batch culture, it will not necessarily
also perform well in more industrial settings, like high cell
density fermentations [108]. It is also possible that muta-
tions cannot be stably maintained when changing culturing
setups. Thus, if one plans to use an evolved protein pro-
duction strain in a more industrial setting, one may want to
test its performance in such a setting early on. However,
even if changing culturing setups leads to instability, it
should be kept in mind that it still may be possible to
isolate suppressors alleviating the instability [108].
Taken together, we envisage that the number of exam-
ples of protein production strains isolated using
evolutionary approaches will grow steadily and that, in
many instances, strains will be isolated for specific target
proteins. Once the use of evolutionary approaches to isolate
protein production strains is more established, combining
evolutionary with directed engineering approaches may
very well open up avenues for the creation of the next
generation of E. coli protein production strains.
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